[Subclinical and established kidney disease in recently diagnosed hypertensive patients]

Manuel Angel Gómez-Marcos1, Carlos Martínez-Salgado, Gonzalo Grandes

  • 1Unidad de Investigación, Centro de Salud La Alamedilla, Salamanca, España. magomez@usal.es

Medicina Clinica
|January 5, 2010
PubMed

Insights

About 20% of newly diagnosed hypertensive patients have renal disease, often undetected by serum creatinine alone. Metabolic syndrome and ankle-arm index are key indicators of this kidney damage.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Context:

  • Hypertension is a prevalent condition associated with significant cardiovascular and renal risks.
  • Early detection of renal disease in hypertensive individuals is crucial for timely intervention.
  • Current screening methods may underestimate the prevalence of renal impairment in this population.

Purpose:

  • To estimate the prevalence of renal disease in recently diagnosed hypertensive patients.
  • To identify factors associated with renal disease in this cohort.
  • To evaluate the utility of serum creatinine, albumin/creatinine index, and glomerular filtration rate (GFR) in detecting renal disease.

Summary:

  • A cross-sectional study of 425 newly diagnosed hypertensive patients revealed a 17.88% prevalence of renal disease.
  • Renal disease was identified using serum creatinine, albumin/creatinine index, and GFR.
  • Metabolic syndrome (OR=11.12) and abnormal ankle-arm index (OR=17.55) were strongly associated with renal disease.
  • Factors related to creatinine included sex, ankle-arm index, and metabolic syndrome; GFR was associated with sex, age, ankle-arm index, metabolic syndrome, and BMI; albumin/creatinine index was linked to diabetes mellitus.

Impact:

  • This study highlights the significant burden of renal disease in hypertensive patients, often missed by standard tests.
  • Identifying key associated factors like metabolic syndrome and ankle-arm index can guide targeted screening and management strategies.
  • Improved detection of renal disease can lead to better cardiovascular and renal outcomes in hypertensive individuals.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...